Prognostic Value of Tumor Mutational Burden Related to Immune Infiltration in Cervical Squamous Cell Carcinoma

Cervical squamous cell carcinoma is one of the most common causes of female cancer deaths worldwide. At present, immunotherapy using immune checkpoint blockade (ICB) has improved the prognosis of many cancer patients, and neoantigens generated by mutations may serve as potential biomarkers for predi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Fang Wen, Shuai Ruan, Wenjie Huang, Xiaoxue Chen, Yulan Wang, Suping Gu, Jiatong Liu, Shenlin Liu, Peng Shu
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/f7fabf8f6eef4f95a74dfcc87a59ed5f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:f7fabf8f6eef4f95a74dfcc87a59ed5f
record_format dspace
spelling oai:doaj.org-article:f7fabf8f6eef4f95a74dfcc87a59ed5f2021-11-11T06:27:23ZPrognostic Value of Tumor Mutational Burden Related to Immune Infiltration in Cervical Squamous Cell Carcinoma2296-858X10.3389/fmed.2021.755657https://doaj.org/article/f7fabf8f6eef4f95a74dfcc87a59ed5f2021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fmed.2021.755657/fullhttps://doaj.org/toc/2296-858XCervical squamous cell carcinoma is one of the most common causes of female cancer deaths worldwide. At present, immunotherapy using immune checkpoint blockade (ICB) has improved the prognosis of many cancer patients, and neoantigens generated by mutations may serve as potential biomarkers for predicting the outcome of ICB therapy. In this study, we identified missense mutations as the most frequent in landscapes of gene mutation in cervical squamous cell carcinoma (CESC) samples. Patients with higher tumor mutation burden (TMB) presented higher overall survival (OS). In addition, there was a significant correlation between the high TMB group and fractions of most immune cells. Univariate and multivariate Cox regression analyses identified five hub genes (IFNG, SERPINA3, CCL4L2, TNFSF15, and IL1R1) that were used to build a prognostic model. In the prognostic model, the low-risk group achieved better OS. Mutations in the five hub genes mainly affected the infiltration level of CD8+ T cells and dendritic cells. In conclusion, our study is valuable for exploring the role of TMB and its relationship with immune infiltration in CESC. Moreover, the prognosis model may help predict the sensitivity of patients to immunotherapy and provide underlying biomarkers for personalized immunotherapy.Fang WenFang WenFang WenShuai RuanShuai RuanShuai RuanWenjie HuangWenjie HuangWenjie HuangXiaoxue ChenXiaoxue ChenXiaoxue ChenYulan WangYulan WangYulan WangSuping GuSuping GuSuping GuJiatong LiuJiatong LiuJiatong LiuShenlin LiuShenlin LiuShenlin LiuPeng ShuPeng ShuPeng ShuFrontiers Media S.A.articletumor mutation burdenimmune infiltrationprognosiscervical squamous cell carcinomaTCGAMedicine (General)R5-920ENFrontiers in Medicine, Vol 8 (2021)
institution DOAJ
collection DOAJ
language EN
topic tumor mutation burden
immune infiltration
prognosis
cervical squamous cell carcinoma
TCGA
Medicine (General)
R5-920
spellingShingle tumor mutation burden
immune infiltration
prognosis
cervical squamous cell carcinoma
TCGA
Medicine (General)
R5-920
Fang Wen
Fang Wen
Fang Wen
Shuai Ruan
Shuai Ruan
Shuai Ruan
Wenjie Huang
Wenjie Huang
Wenjie Huang
Xiaoxue Chen
Xiaoxue Chen
Xiaoxue Chen
Yulan Wang
Yulan Wang
Yulan Wang
Suping Gu
Suping Gu
Suping Gu
Jiatong Liu
Jiatong Liu
Jiatong Liu
Shenlin Liu
Shenlin Liu
Shenlin Liu
Peng Shu
Peng Shu
Peng Shu
Prognostic Value of Tumor Mutational Burden Related to Immune Infiltration in Cervical Squamous Cell Carcinoma
description Cervical squamous cell carcinoma is one of the most common causes of female cancer deaths worldwide. At present, immunotherapy using immune checkpoint blockade (ICB) has improved the prognosis of many cancer patients, and neoantigens generated by mutations may serve as potential biomarkers for predicting the outcome of ICB therapy. In this study, we identified missense mutations as the most frequent in landscapes of gene mutation in cervical squamous cell carcinoma (CESC) samples. Patients with higher tumor mutation burden (TMB) presented higher overall survival (OS). In addition, there was a significant correlation between the high TMB group and fractions of most immune cells. Univariate and multivariate Cox regression analyses identified five hub genes (IFNG, SERPINA3, CCL4L2, TNFSF15, and IL1R1) that were used to build a prognostic model. In the prognostic model, the low-risk group achieved better OS. Mutations in the five hub genes mainly affected the infiltration level of CD8+ T cells and dendritic cells. In conclusion, our study is valuable for exploring the role of TMB and its relationship with immune infiltration in CESC. Moreover, the prognosis model may help predict the sensitivity of patients to immunotherapy and provide underlying biomarkers for personalized immunotherapy.
format article
author Fang Wen
Fang Wen
Fang Wen
Shuai Ruan
Shuai Ruan
Shuai Ruan
Wenjie Huang
Wenjie Huang
Wenjie Huang
Xiaoxue Chen
Xiaoxue Chen
Xiaoxue Chen
Yulan Wang
Yulan Wang
Yulan Wang
Suping Gu
Suping Gu
Suping Gu
Jiatong Liu
Jiatong Liu
Jiatong Liu
Shenlin Liu
Shenlin Liu
Shenlin Liu
Peng Shu
Peng Shu
Peng Shu
author_facet Fang Wen
Fang Wen
Fang Wen
Shuai Ruan
Shuai Ruan
Shuai Ruan
Wenjie Huang
Wenjie Huang
Wenjie Huang
Xiaoxue Chen
Xiaoxue Chen
Xiaoxue Chen
Yulan Wang
Yulan Wang
Yulan Wang
Suping Gu
Suping Gu
Suping Gu
Jiatong Liu
Jiatong Liu
Jiatong Liu
Shenlin Liu
Shenlin Liu
Shenlin Liu
Peng Shu
Peng Shu
Peng Shu
author_sort Fang Wen
title Prognostic Value of Tumor Mutational Burden Related to Immune Infiltration in Cervical Squamous Cell Carcinoma
title_short Prognostic Value of Tumor Mutational Burden Related to Immune Infiltration in Cervical Squamous Cell Carcinoma
title_full Prognostic Value of Tumor Mutational Burden Related to Immune Infiltration in Cervical Squamous Cell Carcinoma
title_fullStr Prognostic Value of Tumor Mutational Burden Related to Immune Infiltration in Cervical Squamous Cell Carcinoma
title_full_unstemmed Prognostic Value of Tumor Mutational Burden Related to Immune Infiltration in Cervical Squamous Cell Carcinoma
title_sort prognostic value of tumor mutational burden related to immune infiltration in cervical squamous cell carcinoma
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/f7fabf8f6eef4f95a74dfcc87a59ed5f
work_keys_str_mv AT fangwen prognosticvalueoftumormutationalburdenrelatedtoimmuneinfiltrationincervicalsquamouscellcarcinoma
AT fangwen prognosticvalueoftumormutationalburdenrelatedtoimmuneinfiltrationincervicalsquamouscellcarcinoma
AT fangwen prognosticvalueoftumormutationalburdenrelatedtoimmuneinfiltrationincervicalsquamouscellcarcinoma
AT shuairuan prognosticvalueoftumormutationalburdenrelatedtoimmuneinfiltrationincervicalsquamouscellcarcinoma
AT shuairuan prognosticvalueoftumormutationalburdenrelatedtoimmuneinfiltrationincervicalsquamouscellcarcinoma
AT shuairuan prognosticvalueoftumormutationalburdenrelatedtoimmuneinfiltrationincervicalsquamouscellcarcinoma
AT wenjiehuang prognosticvalueoftumormutationalburdenrelatedtoimmuneinfiltrationincervicalsquamouscellcarcinoma
AT wenjiehuang prognosticvalueoftumormutationalburdenrelatedtoimmuneinfiltrationincervicalsquamouscellcarcinoma
AT wenjiehuang prognosticvalueoftumormutationalburdenrelatedtoimmuneinfiltrationincervicalsquamouscellcarcinoma
AT xiaoxuechen prognosticvalueoftumormutationalburdenrelatedtoimmuneinfiltrationincervicalsquamouscellcarcinoma
AT xiaoxuechen prognosticvalueoftumormutationalburdenrelatedtoimmuneinfiltrationincervicalsquamouscellcarcinoma
AT xiaoxuechen prognosticvalueoftumormutationalburdenrelatedtoimmuneinfiltrationincervicalsquamouscellcarcinoma
AT yulanwang prognosticvalueoftumormutationalburdenrelatedtoimmuneinfiltrationincervicalsquamouscellcarcinoma
AT yulanwang prognosticvalueoftumormutationalburdenrelatedtoimmuneinfiltrationincervicalsquamouscellcarcinoma
AT yulanwang prognosticvalueoftumormutationalburdenrelatedtoimmuneinfiltrationincervicalsquamouscellcarcinoma
AT supinggu prognosticvalueoftumormutationalburdenrelatedtoimmuneinfiltrationincervicalsquamouscellcarcinoma
AT supinggu prognosticvalueoftumormutationalburdenrelatedtoimmuneinfiltrationincervicalsquamouscellcarcinoma
AT supinggu prognosticvalueoftumormutationalburdenrelatedtoimmuneinfiltrationincervicalsquamouscellcarcinoma
AT jiatongliu prognosticvalueoftumormutationalburdenrelatedtoimmuneinfiltrationincervicalsquamouscellcarcinoma
AT jiatongliu prognosticvalueoftumormutationalburdenrelatedtoimmuneinfiltrationincervicalsquamouscellcarcinoma
AT jiatongliu prognosticvalueoftumormutationalburdenrelatedtoimmuneinfiltrationincervicalsquamouscellcarcinoma
AT shenlinliu prognosticvalueoftumormutationalburdenrelatedtoimmuneinfiltrationincervicalsquamouscellcarcinoma
AT shenlinliu prognosticvalueoftumormutationalburdenrelatedtoimmuneinfiltrationincervicalsquamouscellcarcinoma
AT shenlinliu prognosticvalueoftumormutationalburdenrelatedtoimmuneinfiltrationincervicalsquamouscellcarcinoma
AT pengshu prognosticvalueoftumormutationalburdenrelatedtoimmuneinfiltrationincervicalsquamouscellcarcinoma
AT pengshu prognosticvalueoftumormutationalburdenrelatedtoimmuneinfiltrationincervicalsquamouscellcarcinoma
AT pengshu prognosticvalueoftumormutationalburdenrelatedtoimmuneinfiltrationincervicalsquamouscellcarcinoma
_version_ 1718439553412366336